The authors reply [18]

New England Journal of Medicine

Volumn 354, Issue 15, 2006, Pages 1648-

  Yager, James D ^a   Davidson, Nancy E ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

BREAST CANCER; CANCER RISK; HUMAN; LETTER; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCIENTIFIC LITERATURE;

EID: 33645790307     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc066064     Document Type: Letter

References (3)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
2. Davidson NE, Helzlsouer KJ. Good news about oral contraceptives. N Engl J Med 2002;346:2078-9.
3. Kumle M, Weiderpass E, Braaten T, Persson I, Adami H-O, Lund E. Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 2002;11:1375-81.